STON2 and ovarian carcinoma: Simultaneously, the results of the immunohistochemical staining also provided strong evidence that the STON2 protein, which was intensively expressed in the cytoplasm, was upregulated in the ovarian cancer tissues compared to the normal ovarian tissues (Figure 2C).